#KRAS šÆcancer patient group for reliable Knowledge Research Advocacy & Survivorship. Survival of the strategic. #KickCancersKRAS - š« #KRASholes
International, ALL RAS cancers
Joined February 2020
- Tweets5.2K
- Following4.9K
- Followers4.3K
- Likes12.6K
Pinned Tweet
At @ASCO #GI26 we presented our KRAS KICKERS Trial Finder.
Personalized: KRAS G12D, CRC, US trials
Results (in 4 minutes): 20 trials
go to KRASHUB.ORG
in beta - would love your feedback
abstract
asco.org/abstracts-presentatā¦
FYI:
G12V - 8 trials for CRC
G12R - 7 trials for CRC
KRAS in pediatric cancer!
To open April 2027
Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations
"This phase I/II trial tests the safety, side effects, best dose and how well giving daraxonrasib works for the treatment of pediatric patients with solid tumors with RAS mutations that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory)."
NCT07819838
clinicaltrials.gov/study/NCTā¦
from @COGorg
@frankpmccormick
9
796
KRAS Kickers retweeted
Preliminary clinical results of QTX3034, an oral G12D-preferring KRAS inhibitor with cetuximab Ā± mFOLFOX6 in KRASG12D-mCRC
#ESMO26 #ESMOAmbassadors
šORR: 25% vs 50%, DCR: 75 vs 90%
š no new safety signals
š§Supports the combination with CTx
@myESMO @ASCO
KRAS Kickers retweeted
ICYMI ā©: An @FDA fast track designation was recently granted to QTX3034 plus cetuximab in KRAS G12Dāmutated CRC, marking a milestone for the treatment and field
Full details š: onclive.com/view/qtx3034-pluā¦
#crcsm #oncology
KRAS Kickers retweeted
Nicholas Hornstein Highlights Revolution Medicinesā Fundraising Initiative for KRAS Kickers
@GIMedOnc @KRASKickers
oncodaily.com/community/nichā¦
KRAS Kickers retweeted
Thanks @Sandra_Misale for bringing this to my attention.
Let's support the @KRASKickers. Please retweet and help spread hope for patients and families.
@bryant_kl @BiffiGiulia @LabReichert @UMICHpancreas @KlegerLab @SaurLab @BSIO_Berlin @SivekeJ @Chiolaboratory @KenOliveLab
Please retweet - OR
please send your message of hope
OR both!
Feel free to screenshot your messages! All messages will be collected as part of this shared expression of hope.
@DrDanielKing @DavidHongMD @GarridoLagunaMD @kevansf @Sandra_Misale @EileenMOReilly @BHuffmanMD @BiachiTiago @MPishvaian @AmbrogioLab @FilippoPietran4 @DrShubhamPant @GIcancerDoc @DrMarkAwad @cjder23 @norbertkraut1 @CentralParkWMD @Aiims1742
KRAS Kickers retweeted
@KRASKickers is an incredible patient advocate group and resource for our patients. šŖ
Please take a moment to submit a message of support to patients with KRAS mutated tumors. Revolution Medicine will donate $50 for each message up to $30,000 to @KRASKickers ā¬ļø
This month, Revolution Medicines will donate $50 to @KRASKickers for every message of support submitted for up to $30,000.
Plant a seed of hope. Share your message:
LINK:
"Share a few words of encouragement for people impacted by RAS-addicted cancers. Your message will be collected as part of this shared expression of hope."
revmed.com/revolution-ras/?uā¦
Thank you to @RevMedicines !
KRAS Kickers retweeted
The RAS Revolution will transform RAS cancers! @KRASKickers
This month, Revolution Medicines will donate $50 to @KRASKickers for every message of support submitted for up to $30,000.
Plant a seed of hope. Share your message:
LINK:
"Share a few words of encouragement for people impacted by RAS-addicted cancers. Your message will be collected as part of this shared expression of hope."
revmed.com/revolution-ras/?uā¦
Thank you to @RevMedicines !
ERAS-0015 has become an international trial -
with expansion to South Korea and Canada
AURORAS-1 : A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
NCT06983743
CRC, NSCL, PDAC (even 1st line)
NSCLC patients previously treated with a KRAS G12c inhibitor
KRAS Kickers retweeted
Anyone impacted or working with GI cancer patients should take a moment and offer some words of support to patients battling the disease. KRAS Kickers has been an awesome resource over the years and RevMed is providing significant funding to them (if people click a link and submit a few anonymous words).
@TheGutOncLab @Onco_Nexus @OncoAlert
This month, Revolution Medicines will donate $50 to @KRASKickers for every message of support submitted for up to $30,000.
Plant a seed of hope. Share your message:
LINK:
"Share a few words of encouragement for people impacted by RAS-addicted cancers. Your message will be collected as part of this shared expression of hope."
revmed.com/revolution-ras/?uā¦
Thank you to @RevMedicines !
This month, Revolution Medicines will donate $50 to @KRASKickers for every message of support submitted for up to $30,000.
Plant a seed of hope. Share your message:
LINK:
"Share a few words of encouragement for people impacted by RAS-addicted cancers. Your message will be collected as part of this shared expression of hope."
revmed.com/revolution-ras/?uā¦
Thank you to @RevMedicines !
Our 2023 Season of Thanks padlet.
allowing patients to share pictures of their life and express their thanks for researchers.
padlet.com/kraskickers/a-seaā¦
Beautiful words.
There are so many good people in this world.
Thank you for being one of them.
Anyone impacted or working with GI cancer patients should take a moment and offer some words of support to patients battling the disease. KRAS Kickers has been an awesome resource over the years and RevMed is providing significant funding to them (if people click a link and submit a few anonymous words).
@TheGutOncLab @Onco_Nexus @OncoAlert
KRAS Kickers retweeted
Such a nice initiative that boost even more how much of a great community we areā¤ļøšŖš» please re-tweet and share your message of hope for RAS mutant cancers
@KRASKickers @AndrewMWaters @NeehaZaidi @papkephd @NiloferAzad @DrLizJaffee ā at Towson, MD
Please retweet - OR
please send your message of hope
OR both!
Feel free to screenshot your messages! All messages will be collected as part of this shared expression of hope.
@DrDanielKing @DavidHongMD @GarridoLagunaMD @kevansf @Sandra_Misale @EileenMOReilly @BHuffmanMD @BiachiTiago @MPishvaian @AmbrogioLab @FilippoPietran4 @DrShubhamPant @GIcancerDoc @DrMarkAwad @cjder23 @norbertkraut1 @CentralParkWMD @Aiims1742
Please retweet - OR
please send your message of hope
OR both!
Feel free to screenshot your messages! All messages will be collected as part of this shared expression of hope.
@DrDanielKing @DavidHongMD @GarridoLagunaMD @kevansf @Sandra_Misale @EileenMOReilly @BHuffmanMD @BiachiTiago @MPishvaian @AmbrogioLab @FilippoPietran4 @DrShubhamPant @GIcancerDoc @DrMarkAwad @cjder23 @norbertkraut1 @CentralParkWMD @Aiims1742
This month, Revolution Medicines will donate $50 to @KRASKickers for every message of support submitted for up to $30,000. Plant a seed of hope. Share your message: revmed.com/revolution-ras/?uā¦
"Overall, the drugās sales haul reflects more than 5,000 patients treated in the U.S., coming over the course of just five weeks on the market."
"The transition from the expanded access program to commercial supply has now wrapped up for U.S. patients, the commercialization chief said. "
"While actual launch timing in Europe will depend on that Commission verdict and country-specific access accords, Mancini stressed that RevMed expects to be ready to launch as soon as its able overseas. The company is also working toward a swift rollout in Japan as Rasonque undergoes regulatory review there as well."
Revolution Medicines' Rasonque generated nearly $200M sales in its first five weeks on the market, living up to its much-hyped potential fiercepharma.com/pharma/revmā¦
KRAS Kickers retweeted
Our management team is looking forward to presenting at the upcoming Guggenheim, Wolfe Research, and JefferiesĀ Healthcare Conferences to discuss progress across Verastem's commercialĀ and VS-7375 clinical developmentĀ program. ā
ā
Learn more about the fireside events and webcast details on our Events page: ā
investor.verastem.com/eventsā
ā
$VSTM
